Staphylococci final

55
Dr Reena Kulshrestha, M.Sc, PhD

Transcript of Staphylococci final

Page 1: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 2: Staphylococci final

Classification

• Family

• Genus

• Species

Micrococcaceae

Micrococcus and Staphylococcus

S. aureusS. saprophyticusS. epidermidisM. luteusmore

than 20 species

Dr Reena Kulshrestha, M.Sc, PhD

Page 3: Staphylococci final

INTRODUCTIONStaphyloccocci - derived from Greek “stapyle” (bunch of grapes)

Gram positive cocci arranged in clusters

Hardy organisms surviving many non -physiologic conditions

Include a major human pathogen and skin commensals

Dr Reena Kulshrestha, M.Sc, PhD

Page 4: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 5: Staphylococci final

StreptococcusStaphylococcus

Dr Reena Kulshrestha, M.Sc, PhD

Page 6: Staphylococci final

Grouping for Clinical Purposes1. Coagulase positive Staphylococci

Staphylococcus aureus

2. Coagulase negative StaphylococciStaphylococcus epidermidisStaphylococcus saprophyticus

Dr Reena Kulshrestha, M.Sc, PhD

Page 7: Staphylococci final

Coagulase-negative staphylococcus; frequently involved in nosocomial and opportunistic infections• S. epidermidis – lives on skin and mucous membranes; endocarditis, bacteremia, UTI• S. hominis – lives around apocrine sweat glands• S. capitis – live on scalp, face, external earAll 3 may cause wound infections by penetrating through broken skin• S. saprophyticus – infrequently lives on skin, intestine, vagina; UTI

Dr Reena Kulshrestha, M.Sc, PhD

Page 8: Staphylococci final

A. Staphylococcus aureusMajor human pathogen

Habitat - part of normal flora in some humans and animals

Source of organism - can be infected human host, carrier, fomite or environment

Dr Reena Kulshrestha, M.Sc, PhD

Page 9: Staphylococci final

Grows in large, round, opaque colonies Optimum temperature of 37oC Facultative anaerobe Withstands high salt, extremes in pH, and high temperatures Carried in nasopharynx and skin Produces many virulence factors

Dr Reena Kulshrestha, M.Sc, PhD

Page 10: Staphylococci final

Cultivation of S.aureusTemp. 10-42*C, pH – 7.4 – 7.6Aerobes & facultative anaerobesNutrient Agar – emulsifiable, smooth, shinyColony pigmentation - white, orange &

yellow – at 22*C, aerobic conditins, enhanced with 1% glycerol monoacetate or milk

NA slope – “ oil – paint appearance”Blood Agar – B – hemolysisMac Conkey’s Agar – pink – LF coloniesBroth media – Salt- milk broth, Ludam’s

medium – uniform turbidityDr Reena Kulshrestha, M.Sc, PhD

Page 11: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 12: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 13: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 14: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 15: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 16: Staphylococci final

Cell- associated virulence factors•Capsule or slime layer (glycocalyx) – inhibits opsonisation•Peptidoglycan (PG) – rigidity to cell, activates complement, induces release of inflammatory cytokines•Teichoic acid is covalently linked to PG and is species specific:- Facilitataes adhesion, protects from complement-mediated opsonisation

Dr Reena Kulshrestha, M.Sc, PhD

Page 17: Staphylococci final

S. aureus - ribitol teichoic acid (polysaccharide A)

S. epidermidis- glycerol teichoic acid (polysaccharide B)

•Protein A - is covalently linked to PG-chemotactic, antiphagocytic, anticomplementary, induces platelet damage & hypersensitivity-Binds to Fc terminal of IgG

Dr Reena Kulshrestha, M.Sc, PhD

Page 18: Staphylococci final

•Clumping factor ( bound coagulase )-Surface protein for ‘ Slide Coagulase ’ test- saline suspension of

S.aureus + Human plasma

Cocci are clumped

- Identification of S.aureus- Capsulated strain may not show

Dr Reena Kulshrestha, M.Sc, PhD

Page 19: Staphylococci final

Virulence Factors Extracellular Enzymes

• Coagulase (free) - – Antigenic, acts along with ‘CRF’

• Hyaluronidase – “spreading factor” of S. aureus

(Staphylokinase (fibrinolysin), fatty acid modifying enzymes & proteases )

– Breaks down the connective tissue

• Nuclease– Cleaves DNA and RNA in S.

aureus– Heat stable

Dr Reena Kulshrestha, M.Sc, PhD

Page 20: Staphylococci final

• Protease– Staphylokinase (fibrinolysin)– facilitates adhesion

• Lipases - helps in infecting the skin and sub-

cutaneous tissues• Esterases

Dr Reena Kulshrestha, M.Sc, PhD

Page 21: Staphylococci final

Virulence Factors: Exotoxins•Cytolytic (cytotoxins; cytolysins)- Alpha toxin - hemolysin • Reacts with RBCs, leucocidal, dermonecrotic,

neurotoxic & lethal• Toxic to macrophages, lysosomes, muscle

tissues, renal cortex & circulatory system - Beta toxin• Sphingomyelinase, exhibits ‘ Hot-Cold

phenomenon’- Gamma toxin• Hemolytic activity- Delta toxin• Cytopathic for:• RBCs, Lymphocytes, Neutrophils, Platelets• Enterotoxic activity

Dr Reena Kulshrestha, M.Sc, PhD

Page 22: Staphylococci final

• Leucocidin- ( Panton- Valentine toxin)-2 componenets S & F*Synergohymenotropic toxins (leucocidin+gamma lysin)•Enterotoxin- -Causes Food – poisoning -Nausea, vomiting & diaarhea-IP- 2-6 hrs, Heat stable- 100* for 10- 40 mins-Source of infection – food handler (carrier)-Acts on autonomic nervous system-Potent- ug is toxigenic-Pyrogenic, mitogenic, hypotensive, thrombocytopenic & cytotoxic effects-Diagnosis – Latex agglutination & ELISADr Reena Kulshrestha, M.Sc, PhD

Page 23: Staphylococci final

•Exfoliative toxin (epidermolytic toxin) - ‘ SSSS ’ – exfoliative skin diseases,-– effects new born – ‘Ritter’s disease’ -epidermis gets separated from the underlying tissues-– older patients - Toxic epidermal necrolysis -Milder forms – Pemphigus neonatorum & Bullous impetigo

•Pyrogenic exotoxins- -‘ TSS ’ – fatal multisystem disease – fever, hypotension, myalgia, vomiting, diarhhea, mucosal hyperemia & erythematous rash-Infection of mucosal sites, skin & surgical wounds-Super Ag’s – excessive & dis-regulated Immune Response -activates large no. of T- cells, IL-1 & 2, TNF, INF-y- involves multisystemDr Reena Kulshrestha, M.Sc, PhD

Page 24: Staphylococci final

Natural history of diseaseMany neonates, children, adults -intermittently colonized by S. aureus

Usual sites - skin, nasopharynx, perineum

Breach in mucosal barriers - can enter underlying tissue

Characteristic abscessesDisease due to toxin production

Dr Reena Kulshrestha, M.Sc, PhD

Page 25: Staphylococci final

DISEASESDue to direct effect of organismLocal lesions of skin

Deep abscesses

Systemic infections

Toxin mediatedFood poisoning

toxic shock syndrome

Scalded skin syndrome

Dr Reena Kulshrestha, M.Sc, PhD

Page 26: Staphylococci final

Factors predisposing to S. aureus infections

Host factorsBreach in skinChemotaxis defectsOpsonisation

defectsNeutrophil

functional defectsDiabetes mellitusPresence of foreign

bodies

Pathogen Factors Catalase

(counteracts host defences)

CoagulaseHyaluronidaseLipases (Imp. in

disseminating infection)

B lactasamase(ass. With antibiotic resistance)

Dr Reena Kulshrestha, M.Sc, PhD

Page 27: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 28: Staphylococci final

Pathogenesis•Pass skin – first line of

defense– Benign infection

•Phagocytosis•Antibody•Inflammatory response

– Chronic infections•Delayed hypersensitivity

Dr Reena Kulshrestha, M.Sc, PhD

Page 29: Staphylococci final

SKIN LESIONSBoilsStyesFuruncles(infection of hair follicle)Carbuncles (infection of several hair

follicles)Wound infections(progressive appearance

of swelling and pain in a surgical wound after about 2 days from the surgery)

Impetigo(skin lesion with blisters that break and become covered with crusting exudate)

Dr Reena Kulshrestha, M.Sc, PhD

Page 30: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 31: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 32: Staphylococci final

DEEP ABSCESSSESCan be single or multipleBreast abscess can occur in 1-3% of nursing mothers in puerperiem

Can produce mild to severe disease

Other sites - kidney, brain from septic foci in blood

Dr Reena Kulshrestha, M.Sc, PhD

Page 33: Staphylococci final

Systemic Infections1. With obvious focus

Osteomyelitis, septic arthritis2. No obvious focus

heart (infective endocarditis)Brain(brain abscesses)

3. Ass. With predisposing factors multiple abscesses, septicaemia(IV drug users)

Staphylococcal pneumonia (Post viral)

Dr Reena Kulshrestha, M.Sc, PhD

Page 34: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 35: Staphylococci final

B. TOXIN MEDIATED DISEASES1. Staphylococcal food poisoning

Due to production of entero toxinsheat stable entero toxin acts on gutproduces severe vomiting following a very short incubation period

Resolves on its own within about 24 hours

Dr Reena Kulshrestha, M.Sc, PhD

Page 36: Staphylococci final

2. Toxic shock syndromeHigh fever, diarrhoea, shock and erythematous skin rash which desquamate

Mediated via ‘toxic shock syndrome toxin’10% mortality rateDescribed in two groups of patients

Asso. with young women using tampones during menstruation

Described in young children and men

Dr Reena Kulshrestha, M.Sc, PhD

Page 37: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 38: Staphylococci final

3. Scalded skin syndromeDisease of young childrenMediated through minor Staphylococcal infection by ‘epidermolytic toxin’ producing strains

Mild erythema and blistering of skin followed by shedding of sheets of epidermis

Children are otherwise healthy and most eventually recover

Dr Reena Kulshrestha, M.Sc, PhD

Page 39: Staphylococci final

Antibiotic sensitivity patternVery variable and not predictableVery imp. In Pt. ManagementMechanisms

1.B lactamase production - plasmid mediatedHas made S. aureus resistant to penicillin

group of antibiotics - 90% of S. aureus (Gp A)B lactamase stable penicillins (cloxacillin,

oxacillin, methicillin) used2. Alteration of penicillin binding proteins

(Chromosomal mediated)Has made S. aureus resistant to B lactamase

stable penicillins10-20% S. aureus Gp (B) resistant to all

Penicillins and Cephalasporins)Vancomycin is the drug of choiceDr Reena Kulshrestha, M.Sc, PhD

Page 40: Staphylococci final

Tested in lab using methicillinReferred to as methicillin resistant S.

aureus (MRSA)Emerging problem in the worldIn Sri Lanka prevalence varies from 20-

40% in hospitalsDrug of choice - vancomycinIn Japan emergence of

VIRSA(vancomycin intermediate resistant S. aureus)

No effective antibiotics discovered -We might have to discover

Dr Reena Kulshrestha, M.Sc, PhD

Page 41: Staphylococci final

DIAGNOSIS1. In all pus forming lesions

Gram stain and culture of pus2. In all systemic infections

Blood culture3. In infections of other tissues

Culture of relevant tissue or exudate

Dr Reena Kulshrestha, M.Sc, PhD

Page 42: Staphylococci final

Identification of Staphylococcus in Samples

•Frequently isolated from pus, tissue exudates, sputum, urine, and blood

•Cultivation, catalase, biochemical testing, coagulase

Dr Reena Kulshrestha, M.Sc, PhD

Page 43: Staphylococci final

Mannitol Salts Agar (MSA)

Staphylococcus aureus

Dr Reena Kulshrestha, M.Sc, PhD

Page 44: Staphylococci final

Catalase2H2O2 O2 + 2H2O

Streptococci vs. Staphylococci

Differential Characteristics

Dr Reena Kulshrestha, M.Sc, PhD

Page 45: Staphylococci final

Catalase POS

StaphylococcusCatalase NEG

Dr Reena Kulshrestha, M.Sc, PhD

Page 46: Staphylococci final

S. aureus

Coagulase

Fibrinogen Fibrin

Differential Characteristics

Dr Reena Kulshrestha, M.Sc, PhD

Page 47: Staphylococci final

Dr Reena Kulshrestha, M.Sc, PhD

Page 48: Staphylococci final

Treatment

• Drain infected area• Deep/metastatic infections

– semi-synthetic penicllins– cephalosporins– erythromycin– clindamycin

• Endocarditis– semi-synthetic penicillin + an

aminoglycoside

Dr Reena Kulshrestha, M.Sc, PhD

Page 49: Staphylococci final

Prevention

• Carrier status prevents complete control

• Proper hygiene, segregation of carrier from highly susceptible individuals

• Good aseptic techniques when handling surgical instruments

• Control of nosocomial infections

Dr Reena Kulshrestha, M.Sc, PhD

Page 50: Staphylococci final

2. Staphylococcus epidermidisSkin commensalHas predilection for plastic materialAss. With infection of IV lines,

prosthetic heart valves, shuntsCauses urinary tract infection in

cathetarised patientsHas variable ABS pattern Treatment should be aided with ABST

Dr Reena Kulshrestha, M.Sc, PhD

Page 51: Staphylococci final

S. epidermidisLocation

Normal skin flora opportunistic pathogen

Skin/wound infections Endocarditis UTI

Exposure Direct contact

Newborns Elderly

Fomites Catheters Shunts IV needles Prosthetics

Dr Reena Kulshrestha, M.Sc, PhD

Page 52: Staphylococci final

S. saprophyticusPathogenesis

FimbriaAdhesion proteinsAutolysins

DiseasesUTI/cystitisPeritonitisEnopthalmitisEndocaritisSeptic arthritis

Dr Reena Kulshrestha, M.Sc, PhD

Page 53: Staphylococci final

S. xylosusCommensalIndustry

Ferment meatRed color of sausageFerment milkOrange color of cheese

PathogenicityBiofilmsEnterotoxins

DiseaseNosocomialUTIFood poisoning (raw)

Dr Reena Kulshrestha, M.Sc, PhD

Page 54: Staphylococci final

S. capitisEpidemiology

Skin microbioticaHead predominantly

PathogenicityCoagulase (-)AB resistance

DiseasesValvular endocarditisNeonatal septicemiaOsteomyelitis

Dr Reena Kulshrestha, M.Sc, PhD

Page 55: Staphylococci final

S. pseudointermediusAnimal

microbioticaEpidemiology

ZoonoticEnterotoxins+/- coagulase

DiseasesPyoderma (animals)Food poisoning

Dr Reena Kulshrestha, M.Sc, PhD